Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients From Argentina

NCT07059026 is registered in ClinicalTrials.gov with ITAC (Instituto de Trasplantes y Alta Complejidad) as lead sponsor.

NCT NCT07059026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07059026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients From Argentina
Lead sponsor
ITAC (Instituto de Trasplantes y Alta Complejidad)
Phase
Observational
Overall status
Recruiting
Start date
December 3, 2024
Completion date
December 31, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thrombotic microangiopathy